iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding iTeos Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 77 | 1 | 118 | +42 |
| Shares | 31.2M | 32.0K | 33.4M | +2.28M (+7.3%) |
| Value | $841.3M | $863.0K | $1.55B | +$713.1M (+84.8%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (46)
Institutions that held iTeos Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (4)
Institutions that held iTeos Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| 683 Capital Management, LLC | 200,413 | $5.41M |
| Mirabella Financial Services LLP | 14,280 | $386.0K |
| Boothbay Fund Management, LLC | 9,888 | $267.0K |
| Penserra Capital Management LLC | 805 | $21.0K |
Not filed for Q4 2021 yet (1)
Institutions that held iTeos Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 31,976 | $863.0K |